Sebag M - Search Results

1

A Covalent Cysteine-Targeting Kinase Inhibitor of Ire1 Permits Allosteric Control of Endoribonuclease Activity.

Waller DD, Jansen G, Golizeh M, Martel-Lorion C, Dejgaard K, Shiao TC, Mancuso J, Tsantrizos YS, Roy R, Sebag M, Sleno L, Thomas DY. Waller DD, et al. Among authors: sebag m. Chembiochem. 2016 May 3;17(9):843-51. doi: 10.1002/cbic.201500485. Epub 2016 Mar 7. Chembiochem. 2016. PMID: 26792008

2

Synthesis and Evaluation of Structurally Diverse C-2-Substituted Thienopyrimidine-Based Inhibitors of the Human Geranylgeranyl Pyrophosphate Synthase.

Lee HF, Lacbay CM, Boutin R, Matralis AN, Park J, Waller DD, Guan TL, Sebag M, Tsantrizos YS. Lee HF, et al. Among authors: sebag m. J Med Chem. 2022 Feb 10;65(3):2471-2496. doi: 10.1021/acs.jmedchem.1c01913. Epub 2022 Jan 25. J Med Chem. 2022. PMID: 35077178

3

Unraveling the Prenylation-Cancer Paradox in Multiple Myeloma with Novel Geranylgeranyl Pyrophosphate Synthase (GGPPS) Inhibitors.

Lacbay CM, Waller DD, Park J, Gómez Palou M, Vincent F, Huang XF, Ta V, Berghuis AM, Sebag M, Tsantrizos YS. Lacbay CM, et al. Among authors: sebag m. J Med Chem. 2018 Aug 9;61(15):6904-6917. doi: 10.1021/acs.jmedchem.8b00886. Epub 2018 Jul 25. J Med Chem. 2018. PMID: 30016091

4

Design and synthesis of active site inhibitors of the human farnesyl pyrophosphate synthase: apoptosis and inhibition of ERK phosphorylation in multiple myeloma cells.

Lin YS, Park J, De Schutter JW, Huang XF, Berghuis AM, Sebag M, Tsantrizos YS. Lin YS, et al. Among authors: sebag m. J Med Chem. 2012 Apr 12;55(7):3201-15. doi: 10.1021/jm201657x. Epub 2012 Mar 19. J Med Chem. 2012. PMID: 22390415

5

Thienopyrimidine bisphosphonate (ThPBP) inhibitors of the human farnesyl pyrophosphate synthase: optimization and characterization of the mode of inhibition.

Leung CY, Park J, De Schutter JW, Sebag M, Berghuis AM, Tsantrizos YS. Leung CY, et al. Among authors: sebag m. J Med Chem. 2013 Oct 24;56(20):7939-50. doi: 10.1021/jm400946f. Epub 2013 Oct 3. J Med Chem. 2013. PMID: 23998921

6

Spontaneous remission and clonal evolution in lenalidomide associated secondary AML.

Waller DD, Monczak Y, Michel RP, Shustik C, Sebag M. Waller DD, et al. Among authors: sebag m. Leuk Lymphoma. 2020 Jul;61(7):1724-1727. doi: 10.1080/10428194.2020.1725504. Epub 2020 Feb 20. Leuk Lymphoma. 2020. PMID: 32077352 No abstract available.

7

Oxo-aglaiastatin-Mediated Inhibition of Translation Initiation.

Itoua Maïga R, Cencic R, Chu J, Waller DD, Brown LE, Devine WG, Zhang W, Sebag M, Porco JA Jr, Pelletier J. Itoua Maïga R, et al. Among authors: sebag m. Sci Rep. 2019 Feb 4;9(1):1265. doi: 10.1038/s41598-018-37666-5. Sci Rep. 2019. PMID: 30718665 Free PMC article.

8

IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple Myeloma.

Chong PSY, Zhou J, Lim JSL, Hee YT, Chooi JY, Chung TH, Tan ZT, Zeng Q, Waller DD, Sebag M, Chng WJ. Chong PSY, et al. Among authors: sebag m. Cancer Res. 2019 Sep 15;79(18):4679-4688. doi: 10.1158/0008-5472.CAN-19-0343. Epub 2019 Jul 23. Cancer Res. 2019. PMID: 31337650

9

Longitudinal single-cell analysis of a myeloma mouse model identifies subclonal molecular programs associated with progression.

Croucher DC, Richards LM, Tsofack SP, Waller D, Li Z, Wei EN, Huang XF, Chesi M, Bergsagel PL, Sebag M, Pugh TJ, Trudel S. Croucher DC, et al. Among authors: sebag m. Nat Commun. 2021 Nov 3;12(1):6322. doi: 10.1038/s41467-021-26598-w. Nat Commun. 2021. PMID: 34732728 Free PMC article.

10

CCR1 blockade and myeloma bone disease.

Sebag M. Sebag M. Blood. 2012 Aug 16;120(7):1351-2. doi: 10.1182/blood-2012-06-434019. Blood. 2012. PMID: 22899473 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters